Cargando…

Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome

Functional gastrointestinal disorders (FGIDs) account for at least 40% of all referrals to gastroenterologists. Of the 33 recognized adult FGIDs, irritable bowel syndrome (IBS) is the most prevalent, with a worldwide prevalence estimated at 12%. IBS is an important health care concern as it greatly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacy, Brian E., Patel, Nihal K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704116/ https://www.ncbi.nlm.nih.gov/pubmed/29072609 http://dx.doi.org/10.3390/jcm6110099

Ejemplares similares

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?
por: Park, Moo In
Publicado: (2010)

The Rome Criteria Divides, Distorts and Dilutes the Prevalence of Irritable Bowel Syndrome
por: Gwee, Kok-Ann, et al.
Publicado: (2010)

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?: Author's Reply
por: Park, Dong Won, et al.
Publicado: (2010)

The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson’s Disease Patients According to Rome III Diagnostic Criteria
por: Mishima, Takayasu, et al.
Publicado: (2017)

Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria
por: Miwa, Hiroto
Publicado: (2008)

Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros
por: Ghoshal, Uday C
Publicado: (2017)

The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria
por: WANG, AnJiang, et al.
Publicado: (2008)

The Incidence of Irritable Bowel Syndrome in Children Using the Rome III Criteria and the Effect of Trimebutine Treatment
por: Karabulut, Gülcan S, et al.
Publicado: (2013)

Prevalence of Organic Colonic Lesions by Colonoscopy in Patients Fulfilling ROME IV Criteria of Irritable Bowel Syndrome
por: Paudel, Mukesh Sharma, et al.
Publicado: (2018)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
por: El-Salhy, Magdy, et al.
Publicado: (2019)

The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III
por: Park, Dong Won, et al.
Publicado: (2010)

High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
por: Shiha, Mohamed G., et al.
Publicado: (2020)

Atopic Patients Who Fulfilled Rome III Criteria for Irritable Bowel Syndrome Had Higher Animal Danders Sensitization
por: Siah, Kewin T H, et al.
Publicado: (2020)

Direct healthcare costs of Rome IV or Rome III‐defined irritable bowel syndrome in the United Kingdom
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Subtypes and Symptomatology of Irritable Bowel Syndrome in Children and Adolescents: A School-based Survey Using Rome III Criteria
por: Rajindrajith, Shaman, et al.
Publicado: (2012)

Sensitivity and specificity of mean platelet volume as a laboratory marker for irritable bowel syndrome: Can it be added to Rome criteria?
por: Vaghari-Tabari, Mostafa, et al.
Publicado: (2020)

Awareness and Utilization of ROME Criteria for Diagnosis of Irritable Bowel Syndrome among Primary Care Physicians in Riyadh, Saudi Arabia
por: Al-Shamrani, Hamoud Abdul Aziz, et al.
Publicado: (2020)

Irritable Bowel Syndrome Prevalence among Participants of Woodstock Rock Festival in Poland Based on Rome IV Criteria Questionnaire
por: Palma, Joanna, et al.
Publicado: (2021)

Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia
por: Kanazawa, Motoyori, et al.
Publicado: (2015)

Manning Criteria in Irritable Bowel Syndrome: Its Diagnostic Significance
por: Jeong, Hyeok, et al.
Publicado: (1993)

Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis
por: Zhang, Yan, et al.
Publicado: (2016)

Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life
por: Ozer, Muhammet, et al.
Publicado: (2020)

Irritable bowel syndrome: diagnostic approaches in clinical practice
por: Burbige, Eugene J
Publicado: (2010)

The prevalence of irritable bowel syndrome among Saudi population in Riyadh by use of Rome IV criteria and self-reported dietary restriction
por: Amin, Hussein S., et al.
Publicado: (2021)

Gender Role in Irritable Bowel Syndrome: A Comparison of Irritable Bowel Syndrome Module (ROME III) Between Male and Female Patients
por: Anbardan, Sanam Javid, et al.
Publicado: (2012)

Impact of Rome IV irritable bowel syndrome on work and activities of daily living
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome
por: Goodoory, Vivek C., et al.
Publicado: (2022)

Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions
por: Cangemi, David J., et al.
Publicado: (2019)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Review article: an analysis of safety profiles of treatments for diarrhoea‐predominant irritable bowel syndrome
por: Lacy, Brian E.
Publicado: (2018)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome
por: Lacy, Brian, et al.
Publicado: (2019)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Approaching patients with irritable bowel syndrome
por: Bielefeldt, Klaus
Publicado: (2010)

Variation in Care for Patients with Irritable Bowel Syndrome in the United States
por: Lacy, Brian E., et al.
Publicado: (2016)

Functional Chronic Constipation: Rome III Criteria Versus Rome IV Criteria
por: Russo, Marina, et al.
Publicado: (2019)

Functional Bowel Disorders in Iranian Population using Rome III Criteria
por: Sorouri, Majid, et al.
Publicado: (2010)

A Comprehensive Look at Irritable Bowel Syndrome and its Associated Factors Considering the Rome IV Criteria: A Penalized Smoothly Clipped Absolute Deviation Regression Approach in the Pars Cohort Study
por: Arasteh, Peyman, et al.
Publicado: (2018)

Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria
por: Matsumoto, Seiji, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iceom1t2ctqne4l4nhehqicf63